
New Sepsis Treatment Cuts Death Rate by 30% in Trials
A Kansas City researcher has developed a treatment that could save thousands from sepsis, the condition that kills over 350,000 Americans yearly. Clinical trials show the breakthrough therapy reduced mortality by 30%, with FDA approval possible by 2027.













